Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
15,800
Employees15,800
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
15,800
Employees15,800

EW Key Statistics

Market cap
49.40B
Market cap49.40B
Price-Earnings ratio
36.24
Price-Earnings ratio36.24
Dividend yield
Dividend yield
Average volume
2.75M
Average volume2.75M
High today
$86.00
High today$86.00
Low today
$84.72
Low today$84.72
Open price
$85.79
Open price$85.79
Volume
3.39M
Volume3.39M
52 Week high
$87.89
52 Week high$87.89
52 Week low
$65.94
52 Week low$65.94

Stock Snapshot

The current Edwards Lifesciences(EW) stock price is $85.13, with a market capitalization of 49.4B. The stock trades at a price-to-earnings (P/E) ratio of 36.24.

On 2026-01-11, Edwards Lifesciences(EW) stock moved within a range of $84.72 to $86.00. With shares now at $85.13, the stock is trading +0.5% above its intraday low and -1.0% below the session's peak.

Trading activity shows a volume of 3.39M, compared to an average daily volume of 2.75M.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $87.89 and a low of $65.94.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $87.89 and a low of $65.94.

EW News

TipRanks 4h
Edward Lifesciences Stock Falls as FTC Wins Ruling to Block JenaValve Deal

In a setback to medical-technology company Edward Lifesciences (EW), the U.S. District Court for the District of Columbia ruled in favor of the U.S. Federal Tra...

Nasdaq 2d
U.S. Court Blocks Edwards Lifesciences' Acquisition Of JenaValve; Company Revises 2026 Adj. EPS View

(RTTNews) - Edwards Lifesciences (EW) announced that the U.S. District Court for the District of Columbia has granted the Federal Trade Commission's (FTC) motio...

U.S. Court Blocks Edwards Lifesciences' Acquisition Of JenaValve; Company Revises 2026 Adj. EPS View
TipRanks 2d
Edwards Lifesciences will not acquire JenaValve, updates FY26 guidance

Edwards Lifesciences (EW) announced that the U.S. District Court for the District of Columbia has granted the motion from the U.S. Federal Trade Commission for...

Analyst ratings

69%

of 35 ratings
Buy
68.6%
Hold
31.4%
Sell
0%

More EW News

TipRanks 2d
Edwards Lifesciences upgraded to Buy from Hold at TD Cowen

TD Cowen upgraded Edwards Lifesciences (EW) to Buy from Hold with a price target of $97, up from $90. The firm thinks the company has entered a renewed growth c...

TipRanks 4d
Edwards Lifesciences price target raised to $105 from $100 at Stifel

Stifel analyst Rick Wise raised the firm’s price target on Edwards Lifesciences (EW) to $105 from $100 and keeps a Buy rating on the shares. The firm, which arg...

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.